top of page
Cancer Blog
- Dr. Robert Nagourney -
Search


The Enormous Impact of EVA/PCD Chemosensitivity Testing in Patients with Rare Cancers: Durable Benefit Provided by An Unexpected Recommendation
The drug we recommended, Pazopanib, would not normally be expected to have activity in this rare and aggressive cancer.

Dr. Robert A. Nagourney, MD
Nov 32 min read


Recurrent Hairy Cell Leukemia: Glenn Bernstein
I got the diagnosis after a routine blood test (CBC) during an annual physical exam. I was sent to a specialist who told me I had leukemia.

Dr. Robert A. Nagourney, MD
Mar 29, 20235 min read
bottom of page
